Advanced Medicine

Regeneron’s Gary Herman discusses the future of genetic medicines and the role of new delivery systems.

From overcoming herd mentality in research to expanding cell therapy applications in cancer treatment, we explore the future of pharma.

Lentiviruses are growing in the advanced therapy landscape. Experts at Sartorius discuss the unique challenges that come with their production

The pipeline of early-stage CRISPR therapeutics is huge, but advancing these innovations will require a multifaceted strategy.

The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact

How digital technology has, and will continue to, augment scientific data collection and discovery

Developing science is good; developing successful commercialization strategies is great.

Cell therapy has come a long way since the 1930s. Next, we need to find a way to bring the costs down by using allogeneic approaches.

Jason Bock highlights the need for innovative manufacturing solutions and supply chain improvements in cell therapy.